Webinars
RI-ADE ADME 101: Non-clinical pharmacokinetics studies using radio-labeled compounds
Presenter: Satoshi Ito, Drug Development Solutions Center ADME Group Manager, Sekisui Medical Radio-labeled compounds can be used to provide important information during the drug development process....
Dual-Hybridization PALSAR (Probe Alternation Link Self-Assembly Reaction) Technology Introduction
Presenter: Yuya Ono, MSc, MBA. Sekisui Medical, Co. Ltd. The quantitative bioanalysis of oligonucleotide therapeutics is mainly conducted with LC-MS/MS and hybridization-based ligand binding assays (LBA)....
Design Intricacies and Decision-Making Strategy for Drug-Drug Interaction Studies
Presenter: Andrew G. Taylor, Ph.D., Manager of Technical Support for Services at XenoTech Conducting in vitro ADME drug-drug interaction (DDI) studies early on in the drug...
Highlights of the In Vitro Sections of the Draft ICH Drug Interaction Studies Guideline and Comparison with Current Guidance
Presenter: Brian Ogilvie, Ph.D, Vice President of Scientific Consulting at XenoTech In June 2022, the ICH released the first draft of its harmonized Drug Interaction Studies Guideline (M12). The...
Filing an IND and Beyond: Development of CTD Section 2.6.4, Pharmacokinetics Written Summary
Presenter: Griff Humphreys, Ph.D, XenoTech Consultant Recorded keynote presentation from XenoTech’s 2022 Seminar Series. Learn about what this important section consists of, the studies that...
Role of Sulfotransferases (SULTs) in Drug Metabolism and Potential for Drug-Drug Interactions
Presenter: Maciej Czerwinski, Ph.D., XenoTech Director of Scientific Consulting Abstract: Continuing our series on non-CYP-mediated metabolism pathways, we will be discussing another of the most requested...
Webinar: Bridging In Vitro Data to Clinical Outcomes with MetID
Presenters: Andrew G. Taylor, Ph.D., Manager of Technical Support for Services at XenoTech and Heather Heading, Director of LCMS at Agilex Biolabs Abstract: Profiling, characterising,...
ADME 101: Microsomal Protein Binding of Drugs
Presenter: Kusum Parikh, MBBS, PhD, XenoTech Senior Scientist in Program Oversight Abstract: Regulatory guidance states that drug developers should correct for nonspecific binding in microsomes...
Reactive Metabolite Detection Studies: Cysteine Trapping
Presenter: Miki Fujishima, Manager in Business Development at the Drug Development Solutions Center in Tokai, Japan. Abstract: Drug-induced liver injury (DILI) is caused by various...
Role of UDP-Glucuronosyltransferases (UGTs) in Drug Metabolism and Drug-Drug Interactions
Presenter: Maciej Czerwinski, Ph.D., XenoTech Director of Scientific Consulting Abstract: The importance of glucuronidation for metabolism of xenobiotics in humans is illustrated by the abundance and...
What topic would you like to hear about?
Our experts are constantly on the hunt for new and exciting topics to present on, and nothing helps us figure out what you want to hear more than requests and feedback! Use our form to submit your request so we can continue producing educational materials you look forward to
